Skip to main content

Alexandria REIT lures biotech investors with lab space, not drugs | Reuters

By October 30, 2015News
Alexandria-Real-Estate-Equities-Logo

Alexandria-Real-Estate-Equities-Logo

The booming biotech sector is putting a premium on lab space, and fund managers are buying in.

One of their favorite targets is Pasadena, California-based Alexandria Real Estate Equities Inc, which owns the largest collection of high-end lab space in such research clusters as San Diego, San Francisco and Cambridge, Massachusetts. A total of 64 mutual funds and hedge funds have reported adding shares of the company to their portfolios in the current quarter, a 56 percent jump from the quarter ending in September, according to Morningstar data.

{iframe}http://www.reuters.com/article/2015/10/30/us-alexandria-funds-analysis-idUSKCN0SO0F320151030{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.